it takes a special
kind of character

Character partners with patients, providers, payers, and scientists to create deeply-phenotyped patient cohorts to enable clinical genomic research. Our approach integrates genomics, longitudinal clinical and imaging data, machine learning, and novel experimental approaches to identify the molecular drivers of disease progression and develop innovative targeted medicines.

Since inception, we have built Character to be a patient-driven therapeutics company. Our commitment to patients comes through in the high standards we set to ensure privacy, data security, ethics, scientific rigor and meaningful impact to patient health.

Our Values

We're for people
Safety and privacy always
Ethical transparency in our science
Patient diversity matters
Focus on diseases of aging
Make the greatest health impact
We're for people
Safety and privacy always
Ethical transparency in our science
Patient diversity matters
Focus on diseases of aging
Make the greatest health impact

our team

We are experts from the worlds of drug discovery and development, data science, and clinical research.

Cheng Zhang
CEO, Co-Founder
Marcel van der Brug, PhD
Chief Scientific Officer,
Co-Founder
Erik Karrer, PhD
VP, Drug Discovery
Ben Glicksberg, PhD
VP, Data Science
Amy Park
Sr Clinical Research Coordinator
Andrea Neeranjan
Clinical Research Manager
Brendan Curran
Software Engineer
Geraldine Taveras
Senior Clinical Research Coordinator
Julia Barber
Clinical Data Specialist
Jonathan Gumucio
Senior Scientist
Laura Macri
Clinical Research Manager
Maria Avrutsky
Senior Scientist
Nick Church
Senior Research Associate
Sandeep Adem
Senior Research Associate
Sarah Yuan
Clinical Research Associate
Sumra Farooq
Clinical Research Associate
Yunju Yang
Human Genetics Lead
Nick Johnson
Senior Technology Advisor,
Co-Founder

our board

Joel Dudley
Innovation Endeavors
Peter DiLaura
Lifeforce Capital
Vivek Garipalli
Clover Health
 Cheng Zhang
Character

we're hiring!

Come work with us and make a transformative impact on patient lives.

our investors